Taking Cancer on at Diagnosis Taking Cancer on at Diagnosis We spoke to Markus, Brigitte and Dr Hochmair who shared their advice for people starting their own cancer journeys.
Nerandomilast (BI 1015550): PDE4B inhibitor Nerandomilast (BI 1015550): PDE4B inhibitor Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor Nerandomilast (BI 1015550): PDE4B inhibitor Nerandomilast (BI 1015550): PDE4B inhibitor
Over 100 billion birds vaccinated with VAXXITEK Over 100 billion birds vaccinated with VAXXITEK Boehringer Ingelheim celebrates that over 100 billion birds have been vaccinated with VAXXITEK® HVT + IBD in October 2018.
BI increases commitments to sustainable development BI increases commitments to sustainable development At the World Health Summit 2021, Boehringer Ingelheim announces updates to its strategic approach to sustainable development
Advances in vectored vaccines for poultry Advances in vectored vaccines for poultry Vaccine design technologies have made huge advances in recent years. One of the newer categories of vaccine, vectored vaccines, is overcoming challenges that conventional vaccines do not meet.
Animal Health Partnering Interests Infectious Diseases May 2024 CORP Animal Health Partnering Interests Infectious Diseases May 2024 CORP
Animal Health Partnering Interests Cardiometabolic Diseases May 2024 CORP Animal Health Partnering Interests Cardiometabolic Diseases May 2024 CORP
Animal Health Partnering Interests CNS Diseases May 2024 CORP Animal Health Partnering Interests CNS Diseases May 2024 CORP
Cardiovascular renal and metabolic diseases infographic Cardiovascular renal and metabolic diseases infographic
Partnering in Infectious Diseases MAY 2024 CORP_0.pdf Partnering in Infectious Diseases MAY 2024 CORP_0.pdf
Partnering in Cardiometabolic Diseases MAY 2023 Corp Partnering in Cardiometabolic Diseases MAY 2023 Corp
Partnering in Cardiometabolic Diseases MAY 2024 CORP_0.pdf Partnering in Cardiometabolic Diseases MAY 2024 CORP_0.pdf